FIGO 2023 CLASSIFICATION, THE PATHOLOGIST’S VIEWPOINT

Authors

  • Dr. Camille PASQUESOONE Centre Oscar-Lambret, 3 rue Frédéric Combemale, 59000 Lille.

DOI:

https://doi.org/10.54695/cf.004.1.0005

Keywords:

FIGO 2023, endometrial adenocarcinoma, vascular emboli, TP53 gene mutation, POLE gene mutation.

Abstract

The molecular classification of endometrial carcinoma is now standardized, with prognostic and therapeutic impact based on scientific evidence. This classification is integrated into: the WHO classification, the ESGO-ESTRO-ESP multidisciplinary guidelines
and the new FIGO 2023 classification. The molecular classification of endometrial carcinoma is now standardized with a prognostic and therapeutic impact based on scientific evidence. This classification is integrated into: the WHO classification, the ESGO ESTRO-ESP multidisciplinary guidelines and the new FIGO 2023 classification.

Author Biography

Dr. Camille PASQUESOONE, Centre Oscar-Lambret, 3 rue Frédéric Combemale, 59000 Lille.

Service d’anatomopathologie

Published

2025-07-31

How to Cite

PASQUESOONE, . D. C. . (2025). FIGO 2023 CLASSIFICATION, THE PATHOLOGIST’S VIEWPOINT. Cancers Au Féminin, Actualités Permanentes En Senologie , (1), 5 - 9. https://doi.org/10.54695/cf.004.1.0005

Issue

No. 1 (2025): CANCERS AU FÉMININ

Section

Articles